000 | 01402 a2200421 4500 | ||
---|---|---|---|
005 | 20250511130103.0 | ||
264 | 0 | _c19780223 | |
008 | 197802s 0 0 eng d | ||
022 | _a0078-5334 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJones, D E | |
245 | 0 | 0 |
_aLow dosage combined adrenaline-guanethidine formulations in the management of chronic simple glaucoma. _h[electronic resource] |
260 |
_bTransactions of the ophthalmological societies of the United Kingdom _cApr 1977 |
||
300 |
_a192-5 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aConjunctiva |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEpinephrine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlaucoma _xdrug therapy |
650 | 0 | 4 |
_aGuanethidine _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperemia _xchemically induced |
650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOphthalmic Solutions |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aNorton, D A | |
700 | 1 | _aDavies, D J | |
773 | 0 |
_tTransactions of the ophthalmological societies of the United Kingdom _gvol. 97 _gno. 1 _gp. 192-5 |
|
999 |
_c363378 _d363378 |